Sarıcı Haşmet, Telli Onur, Eroğlu Muzaffer
Clinic of Urology, Ankara Research and Training Hospital, Ankara, Turkey.
Turk J Urol. 2013 Dec;39(4):249-52. doi: 10.5152/tud.2013.062.
Testicular cancer represents 1% to 1.5% of neoplasias in males and 5% of urologic tumors in general. The incidence of bilateral testicular tumors is 1-5%. Approximately one third of the cases are diagnosed as synchronous, while the other two thirds are diagnosed as metachronous tumors. Additionally, 5% of all patients diagnosed with testicular cancer may have contralateral intratubular germ cell neoplasia and may develop a contralateral germ cell tumor. However, few data are available regarding bilateral testicular germ cell tumors (BTGCTs). In this review, we aim to provide an overview of the incidence, pathological features and clinical outcomes.of BTGCTs.
睾丸癌占男性肿瘤的1%至1.5%,占泌尿生殖系统肿瘤的5%。双侧睾丸肿瘤的发生率为1%至5%。约三分之一的病例被诊断为同步性肿瘤,而另外三分之二则被诊断为异时性肿瘤。此外,所有被诊断为睾丸癌的患者中有5%可能患有对侧小管内生殖细胞肿瘤,并可能发展为对侧生殖细胞肿瘤。然而,关于双侧睾丸生殖细胞肿瘤(BTGCTs)的数据很少。在本综述中,我们旨在概述BTGCTs的发病率、病理特征和临床结果。